Nivolumab

ATC L01FF01 · 12 markets · 60 records

Nivolumab 12 markets · 60 records Forms

GB 11 records · 6 strengths

Only this ingredient

Combination products containing this ingredient

  • 240 mg/20 mLinjection CombinationNivolumab 240 mg/20 mL + Relatlimab 80 mg/20 mLOpdualag 240mg/20ml / 80mg/20ml concentrate for solution for infusion vials also in AU

AU 11 records · 10 strengths

Only this ingredient

  • 100 mg/10 mLinjectionOPDIVO also in GB·CN
  • 40 mg/4 mLinjectionOPDIVO also in GB·CN
  • 250 mginjectionOPDIVO nivolumab 240 mg in 24 mL (10 mg/mL) concentrate solution for IV infusion vial unknown
  • 120 mg/mLinjectionOPDIVO SC nivolumab 600 mg in 5 mL (120 mg/mL) solution for injection vial unknown
  • 107 mginjectionOPDIVO nivolumab 40 mg in 4 mL (10 mg/mL) concentrated solution for IV infusion vial unknown
  • 47 mginjectionOPDIVO nivolumab 40 mg in 4 mL (10 mg/mL) concentrated solution for IV infusion vial unknown

Combination products containing this ingredient

  • 240 mg/20 mLinjection CombinationNivolumab 240 mg/20 mL + Relatlimab 80 mg/20 mLOPDUALAG also in GB
  • 255.6 mginjection CombinationNivolumab 255.6 mg + Relatlimab 85.2 mgOPDUALAG nivolumab 240mg and relatlimab 80mg in 20mL concentrate solution for IV infusion vial unknown
3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名OPDIVO ×2OPDIVO SC ×2OPDUALAG ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

ES 8 records · 1 strengths

Only this ingredient

US 7 records · 3 strengths

Only this ingredient

Combination products containing this ingredient

  • 120 mginjection CombinationHyaluronidase (Human Recombinant) 2,000 unit + Nivolumab 120 mgOPDIVO QVANTIG
  • 12 mginjection CombinationNivolumab 12 mg + Relatlimab 4 mgOPDUALAG

CA 5 records · 3 strengths

Only this ingredient

Combination products containing this ingredient

  • 12 mg/1 mLliquid CombinationNivolumab 12 mg/1 mL + Relatlimab 4 mg/1 mLOPDUALAG

HK 3 records · 1 strengths

3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名OPDIVO CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML ×9

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

SG 2 records · 2 strengths

Only this ingredient

  • 10 mg/mLinjectionOPDIVO CONCENTRATE FOR SOLUTION FOR INFUSION 10 MG/ML
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名OPDUALAG CONCENTRATE FOR SOLUTION FOR INFUSION 240MG/80MG ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

CN 2 records · 2 strengths

Only this ingredient

EU 2 records · 2 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名OPDIVO ×2OPDUALAG ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

FR 2 records · 2 strengths

Only this ingredient

  • 10 mg/1 mLinjectionOPDIVO 10 mg/ml, solution a diluer pour perfusion also in ES

Combination products containing this ingredient

  • 12 mg/1 mLinjection CombinationNivolumab 12 mg/1 mL + Relatlimab 4 mg/1 mLOPDUALAG 240 mg/80 mg, solution à diluer pour perfusion

MX 1 records · 1 strengths

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名OPDIVO SC ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

TW 1 records · 1 strengths

Only this ingredient

Also called: 纳武单抗 nickname

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.